Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...

Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...

Officials in Hennepin and Ramsey County are using buprenorphine, a medication to treat opiate withdrawals symptoms that affect a growing number of Minnesotans. More cities are taking notice. As a ...

Lev Facher covers the U.S. addiction and overdose crisis. Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to ...

Patients adherent to SUBLOCADE® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients ...

State laws that ban insurance prior authorization for buprenorphine-a leading medication for opioid use disorder-may not help more patients stay in treatment for the recommended minimum of 180 days, ...

India, March 19 -- Weekly buprenorphine injections demonstrate a superior safety profile compared to daily oral dosing and serve as a highly effective treatment for Opioid Use Disorder (OUD) in ...